<DOC>
	<DOCNO>NCT00002209</DOCNO>
	<brief_summary>The purpose study see safe give multiple dose CPI-1189 HIV-infected , otherwise healthy , male . The study also look CPI-1189 affect level HIV , T cell ( cell body help fight infection ) , three anti-HIV drug ( zidovudine , lamivudine , indinavir ) blood . Advanced HIV infection cause AIDS dementia ( brain damage due HIV leading loss memory muscle control ) . CPI-1189 may able postpone AIDS dementia slow .</brief_summary>
	<brief_title>Safety Effectiveness CPI-1189 HIV-Infected Males Combination Anti-HIV Drug Therapy</brief_title>
	<detailed_description>Late-stage HIV infection cause AIDS dementia ( brain damage due HIV leading loss memory muscle control ) . CPI-1189 may able postpone AIDS dementia slow . In randomized , double-blind study , 48 HIV-infected , otherwise healthy , male volunteer receive either multiple-dose CPI-1189 placebo mouth 15 consecutive day . Each dose group begin 6 week follow start precede group . Volunteers enter study site night dose Days 1 15 remain study site 72 hour follow dosing . Throughout study , volunteer physical exam donate sample blood , urine , cerebrospinal fluid , sperm .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>AIDS Dementia Complex</mesh_term>
	<criteria>Inclusion Criteria You may eligible study : Are HIVpositive man otherwise good health . Are 1850 year old . Have CD4 count 75500 cells/mm3 . Are currently take zidovudine ( ZDV ) , lamivudine ( 3TC ) , indinavir ( IDV ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 1999</verification_date>
	<keyword>Dose-Response Relationship , Drug</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>AIDS Dementia Complex</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Lamivudine</keyword>
	<keyword>Indinavir</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
</DOC>